DS
LMAT icon

David Shaw’s LeMaitre Vascular LMAT Stock Holding History

David Shaw’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.5M Sell
36,464
-47,165
-56% -$4.84M ﹤0.01% 2703
2026
Q1 		$9.13M Buy
83,629
+40,826
+95% +$3.89M 0.01% 1719
2025
Q4 		$3.47M Sell
42,803
-3,902
-8% -$336K ﹤0.01% 2607
2025
Q3 		$4.09M Buy
46,705
+34,408
+280% +$3.07M ﹤0.01% 2387
2025
Q2 		$1.02M Sell
12,297
-42,716
-78% -$3.57M ﹤0.01% 3224
2025
Q1 		$4.62M Buy
55,013
+36,442
+196% +$3.39M ﹤0.01% 1956
2024
Q4 		$1.71M Sell
18,571
-31,233
-63% -$3M ﹤0.01% 2841
2024
Q3 		$4.63M Buy
49,804
+20,329
+69% +$1.76M ﹤0.01% 2007
2024
Q2 		$2.43M Buy
+29,475
New +$2.17M ﹤0.01% 2485
2024
Q1 		– Sell
-9,129
Closed -$518K – 4565
2023
Q4 		$518K Sell
9,129
-27,796
-75% -$1.46M ﹤0.01% 3497
2023
Q3 		$2.01M Sell
36,925
-24,667
-40% -$1.46M ﹤0.01% 2559
2023
Q2 		$4.14M Buy
+61,592
New +$3.76M ﹤0.01% 2012
2021
Q3 		– Sell
-4,619
Closed -$282K – 5095
2021
Q2 		$282K Sell
4,619
-14,012
-75% -$744K ﹤0.01% 4310
2021
Q1 		$909K Buy
18,631
+5,555
+42% +$260K ﹤0.01% 3190
2020
Q4 		$530K Buy
+13,076
New +$467K ﹤0.01% 3361
2019
Q4 		– Sell
-10,745
Closed -$367K – 4076
2019
Q3 		$367K Buy
10,745
+2,838
+36% +$90.7K ﹤0.01% 3354
2019
Q2 		$221K Sell
7,907
-300
-4% -$8.34K ﹤0.01% 3430
2019
Q1 		$254K Buy
+8,207
New +$219K ﹤0.01% 3288
2016
Q4 		– Sell
-30,808
Closed -$611K – 3528
2016
Q3 		$611K Buy
+30,808
New +$538K ﹤0.01% 2679

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

David Shaw's LMAT Position: Q2 2026 in Review

David Shaw reduced its LeMaitre Vascular (LMAT) stake by 56% in Q2 2026, selling an estimated $4.84M and leaving 36,464 shares worth $3.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2703.

David Shaw first reported a position in LMAT in Q3 2016 and has held it in 19 quarters since. The position peaked at $9.13M in Q1 2026. 325 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • David Shaw held 36,464 shares of LeMaitre Vascular worth $3.5M as of Q2 2026.
  • David Shaw sold 47,165 LeMaitre Vascular shares in Q2 2026, an estimated $4.84M.
  • LeMaitre Vascular made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2703 holding.
  • David Shaw first reported a position in LeMaitre Vascular in Q3 2016 and has held it in 19 quarters since.
  • David Shaw's LeMaitre Vascular position peaked at $9.13M in Q1 2026.
  • 325 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.